2.3 In vivo efficacy in hGIPR DIO mice To determine the effects of AB106-156 as a monotherapy and in combination with the GLP-1 receptor agonist semaglutide on weight loss, 25-week-old diet-induced obese hGIPR mice (DIO) were obtained and maintained on a high fat diet (60 % kcal from fat)
While there is no official research specifically about semaglutide and insomnia, a social media study found user complaints about disrupted sleep as a result of the medication
(But) this is exactly why many patients experience nausea and even vomiting with the GLP-1 medications. Some foods may stay in the stomach for many hours or even days when taking these drugs, he notes
Symptoms may include chills, cold sweat, dizziness, drowsiness, shaking, fast heartbeat, weakness, headache, fainting, tingling of the hands or feet, or hunger